Low-dose whole thorax radiation therapy for COVID-19 pneumonia: inpatient onboarding process for a randomized controlled trial

BACKGROUND: The mortality of the SARS-CoV-2 virus (COVID-19) has been associated with a pulmonary inflammatory response resulting in hypoxemia and rapid clinical decline. PREVENT is an ongoing prospective multicenter Phase II randomized controlled trial where patients hospitalized with COVID-19 pneu...

Descripción completa

Detalles Bibliográficos
Autores principales: McClelland, Shearwood, Miller, Amy C., Williams, Mark D., Anthony, Benjamin P., Chakravarti, Arnab, Anthony, Paul A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8726436/
https://www.ncbi.nlm.nih.gov/pubmed/34992881
http://dx.doi.org/10.5603/RPOR.a2021.0112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8726436/
https://www.ncbi.nlm.nih.gov/pubmed/34992881
http://dx.doi.org/10.5603/RPOR.a2021.0112

Ejemplares similares